Globus Medical Inc logo

GMED - Globus Medical Inc Share Price

$57.82 7.2  14.1%

Last Trade - 06/08/20

Large Cap
Market Cap £4.31bn
Enterprise Value £4.10bn
Revenue £603.2m
Position in Universe 1044th / 6362
Unlock GMED Revenue
Relative Strength (%)
1m +21.7%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.87%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
474.4 544.8 564 636 713 785.4 676.4 863 +10.6%
+11.8 +11.1 -0.3 +11.0 +29.6 -2.9 -43.7 +103.4
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Globus Medical Inc revenues increased 4% to $190.6M. Net income decreased 22% to $25.9M. Revenues reflect United States segment increase of 7% to $158.4M. Net income was offset by Selling, general and administrative increase of 9% to $93.5M (expense), Research and development increase of 8% to $15.4M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $0.34 to $0.26.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for GMED
Graphical History


GMED Revenue Unlock GMED Revenue

Net Income

GMED Net Income Unlock GMED Revenue

Normalised EPS

GMED Normalised EPS Unlock GMED Revenue

PE Ratio Range

GMED PE Ratio Range Unlock GMED Revenue

Dividend Yield Range

GMED Dividend Yield Range Unlock GMED Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GMED EPS Forecasts Unlock GMED Revenue
Profile Summary

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated March 3, 2003
Public Since March 8, 2012
No. of Shareholders: 48
No. of Employees: 2,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange New York Stock Exchange
Shares in Issue 98,094,000
Free Float (0.0%)
Eligible for
GMED Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GMED
Upcoming Events for GMED
Wednesday 4th November, 2020 Estimate
Q3 2020 Globus Medical Inc Earnings Release
Frequently Asked Questions for Globus Medical Inc
What is the Globus Medical Inc share price?

As of 06/08/20, shares in Globus Medical Inc are trading at $57.82, giving the company a market capitalisation of £4.31bn. This share price information is delayed by 15 minutes.

How has the Globus Medical Inc share price performed this year?

Shares in Globus Medical Inc are currently trading at $57.82 and the price has moved by 18.92% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Globus Medical Inc price has moved by 5% over the past year.

What are the analyst and broker recommendations for Globus Medical Inc?

Of the analysts with advisory recommendations for Globus Medical Inc, there are there are currently 3 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Globus Medical Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Globus Medical Inc next release its financial results?

Globus Medical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Globus Medical Inc dividend yield?

Globus Medical Inc does not currently pay a dividend.

Does Globus Medical Inc pay a dividend?

Globus Medical Inc does not currently pay a dividend.

When does Globus Medical Inc next pay dividends?

Globus Medical Inc does not currently pay a dividend.

How do I buy Globus Medical Inc shares?

To buy shares in Globus Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Globus Medical Inc?

Shares in Globus Medical Inc are currently trading at $57.82, giving the company a market capitalisation of £4.31bn.

Where are Globus Medical Inc shares listed? Where are Globus Medical Inc shares listed?

Here are the trading details for Globus Medical Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: GMED
What kind of share is Globus Medical Inc?

Based on an overall assessment of its quality, value and momentum, Globus Medical Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Globus Medical Inc share price forecast 2020?

Shares in Globus Medical Inc are currently priced at $57.82. At that level they are trading at 3.15% premium to the analyst consensus target price of 0.00.

Analysts covering Globus Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.878 for the next financial year.

How can I tell whether the Globus Medical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Globus Medical Inc. Over the past six months, the relative strength of its shares against the market has been 9.19%. At the current price of $57.82, shares in Globus Medical Inc are trading at 14.74% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Globus Medical Inc PE Ratio?

The Globus Medical Inc PE ratio based on its reported earnings over the past 12 months is 38.93. The shares are currently trading at $57.82.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Globus Medical Inc?

Globus Medical Inc's management team is headed by:

David Paul - CHM
David Demski - PRE
David Davidar - IND
Daniel Lemaitre - IND
Ann Rhoads - IND
Daniel Scavilla - EVP
James Tobin - IND
Keith Pfeil - CFO
Robert Douglas - IND
Kelly Huller - SVP
Who are the major shareholders of Globus Medical Inc?

Here are the top five shareholders of Globus Medical Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 11.33% (8.49m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10% (7.49m shares)
Janus Henderson Investors Investment Advisor/Hedge Fund
Percentage owned: 9.04% (6.77m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 5.04% (3.78m shares)
Janus Henderson Triton Fund Mutual Fund
Percentage owned: 3.5% (2.62m shares)
Similar to GMED
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.